Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America

NCT00312663 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

FED

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: Falciparum Malaria Protein 11 with AS01B adjuvant.

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]
[object Object]